Catalent - Asia-Pacific clinical packaging facilities
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

30

May 2020

Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer

Daiichi Sankyo Company Limited announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck Co Inc Kenilworth New Jersey USA known as MSD outside the United States and Canada to evaluate the combination of DS a TROP directed DXd antibody drug conjugate ADC...

30

May 2020

Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases

Ligand Pharmaceuticals Incorporated and Icagen a Ligand Company announced today the expansion of Icagens license agreement with Roche to develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders by adding a second program to the agreement The new pro...

29

May 2020

RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy With Merck’s KEYTRUDA® for Certain Late-Stage Cancers

RefleXion Medical a therapeutic oncology company pioneering biologyguided radiotherapy BgRT for treating all stages of cancer today announced a clinical collaboration with Merck known as MSD outside the US and Canada to evaluate the safety and efficacy of KEYTRUDA pembrolizumab Mercks antiPD therapy...

29

May 2020

CordenPharma and Moderna collaborate in obtaining the coronavirus vaccine

CordenPharma a fullservice contract manufacturing and development CDMO organization for the supply of APIs Drug Products and Pharmaceutical Packaging announces the signing of a modification to its agreement to with existing manufacturing Modern Inc a clinical phase biotechnology company pioneering...

28

May 2020

EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer

EdiGene Inc which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases and Immunochinaa company dedicated to innovative gene and cellular technology announced that they have formed a research and development collaboration to d...

28

May 2020

Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

Gilead Sciences Inc and Arcus Biosciences Inc an oncologyfocused biopharmaceutical company working to create bestinclass cancer therapeutics announced today that the companies have entered into a year partnership to codevelop and cocommercialize current and future therapeutic product candidates in A...

27

May 2020

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

Repare Therapeutics Inc Repare a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations today announced it has entered into an exclusive worldwide research collaboration with Br...

press releasesRead more...

30

May 2020

Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pneumonia (CAP)

Nabriva Therapeutics plc announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending approval of XENLETA lefamulin for the treatment of communityacquired pneumonia CAP in adults when it is considered inappro...

30

May 2020

Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen

Johnson Johnson announced that its Janssen Pharmaceutical Companies received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA for its investigational Ebola vaccine regimen for the prevention of the Ebola Virus Disease caused by the...

29

May 2020

Merck Expands Emprove® Portfolio with Chromatography Resins

Merck has expanded its Emprove Portfolio with its Fractogel Eshmuno and ProSep chromatography resins providing comprehensive product information to facilitate and accelerate selection qualification risk assessment and support regulatory filings These chromatography resins join more than raw and sta...

29

May 2020

Vetter Wins Axia Best Managed Companies Award

A look at vital figures makes it clear that Vetter is a very successful globally active Contract Development and Manufacturing Organization CDMO Over the last ten years the company has more than doubled its annual sales revenues to approximately million euros while the number of staff members has g...

29

May 2020

Premier Inc. ProvideGx™ Program Partners with Hikma Pharmaceuticals to Secure the Supply of Two Drugs Essential for COVID-19 Patient Care

Premier Inc through its ProvideGx program has partnered with Hikma Pharmaceuticals PLC Hikma Group to supply amiodarone and sterile water to healthcare providers helping to stabilize the longterm supply of two medications vital for COVID patient care

29

May 2020

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer's Disease

The US Food and Drug Administration approved Tauvid flortaucipir F for intravenous injection the first drug used to help image a distinctive characteristic of Alzheimers disease in the brain called tau pathology Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment wh...

28

May 2020

Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility

Rentschler Biopharma SE a leading global contract development and manufacturing organization CDMO for biopharmaceuticals announced today that the company has entered into a strategic collaboration with Genmab for the process development and manufacture of bispecific antibodies generated with Genmabs...

EventsRead more...

02 - 22

Jun 2020

03 - 04

Jun 2020

Parkinson's and Movement Disorders

Pulsus Conference
Vienna

08 - 09

Jun 2020

10 - 11

Jun 2020

15 - 17

Jun 2020

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Innovation Management At Bachem

    Innovation Management at Bachem

    Chief Technology Officer, Bachem Holding AG

    Gnther Loidl joined Bachem in He held several functions in Research and Development RD and Active Pharmaceutical Ingredient Manufacturing and became Vice President RD in Since he is CTO of the Bachem Group and a member of the Corporate Executive C...
  • Techno Trends

    First-of-its-kind Clinical Trial Monitoring Service Launched for Cancer Patients

    Specimatch the first continual clinical trial monitoring service announces the launch of its webbased software service for cancer patients Users can easily connect to clinical trials personally matched to the patients genetic and clinical profiles through Specimatchcom This software is a solution for patients and oncologists to tap into a complex landscape of break...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...